Compare KZIA & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZIA | EHTH |
|---|---|---|
| Founded | 1994 | 1997 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 104.0M |
| IPO Year | 2002 | 2006 |
| Metric | KZIA | EHTH |
|---|---|---|
| Price | $12.95 | $1.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $19.50 | $3.33 |
| AVG Volume (30 Days) | 229.2K | ★ 326.8K |
| Earning Date | 06-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $251,395,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 45.86 |
| 52 Week Low | $3.30 | $1.20 |
| 52 Week High | $17.40 | $5.89 |
| Indicator | KZIA | EHTH |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 43.42 |
| Support Level | $5.71 | $1.64 |
| Resistance Level | $14.82 | $1.72 |
| Average True Range (ATR) | 1.03 | 0.14 |
| MACD | -0.30 | -0.03 |
| Stochastic Oscillator | 35.24 | 7.75 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.